Evidence map›Paper›PMID 42283777›Full record

ArticleGeroScience2026

External validation of a US claims-based frailty indicator and development of a population-specific model for the German healthcare system.

Nina Mielke, Damiano Ferrari, Muhammad Helmi Barghouth, Natalie Ebert, Janine Kaiser, Elke Schaeffner

Abstract read
PubMed Publisher
In one paragraph

Article in GeroScience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nina MielkeInstitute of Public Health, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany. nina.mielke@charite.de.ORCID http://orcid.org/0000-0002-8951-9823
Damiano FerrariInstitute of Public Health, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.ORCID http://orcid.org/0009-0008-4395-7415
Muhammad Helmi BarghouthInstitute of Public Health, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.ORCID http://orcid.org/0000-0002-5721-9367
Natalie EbertInstitute of Public Health, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.ORCID http://orcid.org/0000-0002-4463-3315
Janine KaiserInstitute of Public Health, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.ORCID http://orcid.org/0009-0000-4423-0148
Elke SchaeffnerInstitute of Public Health, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Charitéplatz 1, 10117, Berlin, Germany.ORCID http://orcid.org/0000-0002-7925-4577

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Frailty increases the risk of adverse outcomes in older adults and is an important target for preventive care. Clinical frailty measures are established but rarely available at scale due to limited functional data in routine healthcare records. Claims-based frailty prediction models offer a pragmatic approach for population-level risk stratification but are often developed in specific healthcare systems and lack external validation. We aimed to externally validate and recalibrate the Claims-Based-Frailty-Indicator (CFI) and develop a claims-based frailty model for the German healthcare context. We used data from the Berlin Initiative Study, a cohort of older adults with assessment of the frailty phenotype, linked to individual health insurance claims and cause-of-death data. External validation of CFI was assessed by discrimination and calibration. Additionally, a new claims-based frailty model was developed. Model performance and application were evaluated through associations with mortality and hospital admission. Reporting followed TRIPOD statement. Among 1,151 participants (mean age 84.4 years; 55% women), the CFI demonstrated good discrimination (AUC 0.78) but poor calibration; recalibration of intercept improved calibration. Maximizing the Youden Index identified an optimal frailty threshold corresponding to a predicted probability of 0.39. The new model showed improved discrimination (AUC 0.82). Predicted frailty was similarly associated with mortality and hospital admissions as the frailty phenotype. Claims-based frailty models can be validated, recalibrated, and adapted to the German healthcare system. They provide a feasible approach for population-level frailty assessment and may support health services research, risk stratification, and care planning for older adults.

Indexed as

Claims dataExternal validationFrailty phenotypePredictionVery old adults

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.